Blondel Hazel

Array ( [id] => 2322794 [patent_doc_number] => 04636383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-01-13 [patent_title] => 'Interferon-cyclaradine combination' [patent_app_type] => 1 [patent_app_number] => 6/645370 [patent_app_country] => US [patent_app_date] => 1984-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2073 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/636/04636383.pdf [firstpage_image] =>[orig_patent_app_number] => 645370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2391291 [patent_doc_number] => 04769239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-09-06 [patent_title] => 'Vaccine against varicella-zoster virus' [patent_app_type] => 1 [patent_app_number] => 6/642983 [patent_app_country] => US [patent_app_date] => 1984-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3619 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/769/04769239.pdf [firstpage_image] =>[orig_patent_app_number] => 642983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2394349 [patent_doc_number] => 04782142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-01 [patent_title] => 'Novel 5-substituted 2-pyrimidinone nucleosides and methods of use' [patent_app_type] => 1 [patent_app_number] => 6/641770 [patent_app_country] => US [patent_app_date] => 1984-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5046 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/782/04782142.pdf [firstpage_image] =>[orig_patent_app_number] => 641770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361897 [patent_doc_number] => 04658020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-14 [patent_title] => 'Monoclonal antibody to human helper T cells' [patent_app_type] => 1 [patent_app_number] => 6/639554 [patent_app_country] => US [patent_app_date] => 1984-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7812 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/658/04658020.pdf [firstpage_image] =>[orig_patent_app_number] => 639554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2299597 [patent_doc_number] => 04681930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-07-21 [patent_title] => 'Immune interferon and a method for its extraction and purification' [patent_app_type] => 1 [patent_app_number] => 6/639551 [patent_app_country] => US [patent_app_date] => 1984-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7730 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/681/04681930.pdf [firstpage_image] =>[orig_patent_app_number] => 639551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2326018 [patent_doc_number] => 04680383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-07-14 [patent_title] => 'Monoclonal antibody to human T cells' [patent_app_type] => 1 [patent_app_number] => 6/639563 [patent_app_country] => US [patent_app_date] => 1984-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 6266 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/680/04680383.pdf [firstpage_image] =>[orig_patent_app_number] => 639563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361893 [patent_doc_number] => 04658019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-14 [patent_title] => 'Complement-fixing monoclonal antibody to human T cells' [patent_app_type] => 1 [patent_app_number] => 6/639552 [patent_app_country] => US [patent_app_date] => 1984-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 5774 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/658/04658019.pdf [firstpage_image] =>[orig_patent_app_number] => 639552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2339394 [patent_doc_number] => 04661348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-28 [patent_title] => 'Babesiosis antigen and method for preparation' [patent_app_type] => 1 [patent_app_number] => 6/631547 [patent_app_country] => US [patent_app_date] => 1984-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2736 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/661/04661348.pdf [firstpage_image] =>[orig_patent_app_number] => 631547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2384565 [patent_doc_number] => 04707358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-11-17 [patent_title] => 'Vaccine against Epstein-Barr Virus' [patent_app_type] => 1 [patent_app_number] => 6/633558 [patent_app_country] => US [patent_app_date] => 1984-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5327 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 922 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/707/04707358.pdf [firstpage_image] =>[orig_patent_app_number] => 633558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2413039 [patent_doc_number] => 04743553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-10 [patent_title] => 'Synthetic genes for bovine parainfluenza virus' [patent_app_type] => 1 [patent_app_number] => 6/632106 [patent_app_country] => US [patent_app_date] => 1984-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 8948 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/743/04743553.pdf [firstpage_image] =>[orig_patent_app_number] => 632106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2258066 [patent_doc_number] => 04618578 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-10-21 [patent_title] => 'Expression of glycoprotein D of herpes simplex virus' [patent_app_type] => 1 [patent_app_number] => 6/631669 [patent_app_country] => US [patent_app_date] => 1984-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7287 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/618/04618578.pdf [firstpage_image] =>[orig_patent_app_number] => 631669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2258164 [patent_doc_number] => 04618585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-10-21 [patent_title] => 'Hybridoma cell lines producing monoclonal antibodies directed against cervical cancer cells' [patent_app_type] => 1 [patent_app_number] => 6/631252 [patent_app_country] => US [patent_app_date] => 1984-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2668 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/618/04618585.pdf [firstpage_image] =>[orig_patent_app_number] => 631252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2224587 [patent_doc_number] => 04624918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-11-25 [patent_title] => 'Purification process for hepatitis surface antigen and product thereof' [patent_app_type] => 1 [patent_app_number] => 6/629295 [patent_app_country] => US [patent_app_date] => 1984-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5120 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/624/04624918.pdf [firstpage_image] =>[orig_patent_app_number] => 629295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2215579 [patent_doc_number] => 04614651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-09-30 [patent_title] => 'Interferon epsilon' [patent_app_type] => 1 [patent_app_number] => 6/628327 [patent_app_country] => US [patent_app_date] => 1984-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3962 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/614/04614651.pdf [firstpage_image] =>[orig_patent_app_number] => 628327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2362649 [patent_doc_number] => 04666887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-05-19 [patent_title] => 'Intravenous or intraperitoneal administration of a tripeptide compound for treating cancer' [patent_app_type] => 1 [patent_app_number] => 6/626938 [patent_app_country] => US [patent_app_date] => 1984-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4402 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/666/04666887.pdf [firstpage_image] =>[orig_patent_app_number] => 626938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2290152 [patent_doc_number] => 04639372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-01-27 [patent_title] => 'Coccidiosis vaccine' [patent_app_type] => 1 [patent_app_number] => 6/625882 [patent_app_country] => US [patent_app_date] => 1984-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3667 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/639/04639372.pdf [firstpage_image] =>[orig_patent_app_number] => 625882 [rel_patent_id] =>[rel_patent_doc_number] =>)